Accurate Assessment of Adherence
The DOI matches its Crossref record, with a small difference in title or year; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Background People with cystic fibrosis have a high treatment burden. While uncertainty remains about individual patient level of adherence to medication, treatment regimens are difficult to tailor, and interventions are difficult to evaluate. Self- and clinician-reported measures are routinely used despite criticism that they overestimate adherence. This study assessed agreement between rates of adherence to prescribed nebulizer treatments when measured by self-report, clinician report, and electronic monitoring suitable for long-term use. Methods Seventy-eight adults with cystic fibrosis were questioned about their adherence to prescribed nebulizer treatments over the previous 3 months. Self-report was compared with clinician report and stored adherence data downloaded from the I-Neb nebulizer system. Adherence measures were expressed as a percentage of the prescribed regimen, bias was estimated by the paired difference in mean (95% CI) patient and clinician reported and actual adherence. Agreement between adherence measures was calculated using intraclass correlation coefficients (95% CI), and disagreements for individuals were displayed using Bland-Altman plots. Results Patient-identified prescriptions matched the medical record prescription. Median self-reported adherence was 80% (interquartile range, 60%-95%), whereas median adherence measured by nebulizer download was 36% (interquartile range, 5%-84.5%). Nine participants overmedicated and underreported adherence. Media…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some trials also highlighted a possible ceiling effect (Quinn 2004; Wildman 2022), as their recruited participants had baseline adherence rates already higher than 'real world' adherence (Daniels 2011;Hoo 2019;Hoo 2020;Hoo 2021).”
From Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis (2023) · cites this paper as Daniels 2011
In the citing paper
“This is promising as it shows that the methodology is advancing alongside evidence that highlights the discrepancy between objective and subjective measures of adherence (Daniels 2011; Thorton”
From Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis (2023) · cites this paper as Daniels 2011
In the citing paper
“The discrepancy between objective and subjective measurement has also been highlighted (Daniels 2011;Modi 2006b;Thorton 2013;Warnock 2020).”
From Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis (2023) · cites this paper as Daniels 2011
In the citing paper
“Trials using objective recorded measures suggest that adherence to inhaled therapies in people with CF is around 31% to 36% in adults (Daniels 2011;Hoo 2019;Hoo 2020;Hoo 2021)”
From Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis (2023) · cites this paper as Daniels 2011
In the citing paper
“Despite previous research highlighting the discrepancy between objective and subjective methods of measuring adherence to inhaled therapies in people with CF (Daniels 2011; Thorton 2013; Warnock 2020), objective measures are rarely used in practice (Robinson 2020).”
From Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis (2023) · cites this paper as Daniels 2011
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Inhaled bronchodilators for cystic fibrosis
Halfhide, C. P., Evans, H. J., & Couriel, J. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003428.pub2 · Cited by 66
RetractedSTATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
(1965) · The Lancet · doi:10.1016/s0140-6736(65)91037-8 · Cited by 16,856
A systematic review of adherence with medications for diabetes
Cramer, J. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1218 · Cited by 1,203
The diagnosis of cystic fibrosis: A consensus statement
Rosenstein, B. J., & Cutting, G. R. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70344-0 · Cited by 1,086
High treatment burden in adults with cystic fibrosis: challenges to disease self-management
Sawicki, G. S., Sellers, D. E., & Robinson, W. M. (2009) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.09.007 · Cited by 498
Evidence-based Assessment of Adherence to Medical Treatments in Pediatric Psychology
Quittner, A. L., Modi, A. C., Lemanek, K. L., Ievers-Landis, C. E., & Rapoff, M. A. (2008) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsm064 · Cited by 329
Barriers to Treatment Adherence for Children with Cystic Fibrosis and Asthma: What Gets in the Way?
Modi, A. C., & Quittner, A. L. (2006) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsj096 · Cited by 301
A multi-method assessment of treatment adherence for children with cystic fibrosis
Modi, A. C., Lim, C. S., Yu, N., Geller, D., Wagner, M. H., & Quittner, A. L. (2006) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2006.03.002 · Cited by 265
Treatment compliance in adults with cystic fibrosis.
Abbott, J., Dodd, M., Bilton, D., & Webb, A. K. (1994) · Thorax · doi:10.1136/thx.49.2.115 · Cited by 188
Research works printed but not linked: 3
- Dodd, 1998, The medical and economic consequences of non-compliance in clinical trials and in primary care [Abstract], Thorax, 53, A18
- Nikander, 2008, Use of I-Neb Insight to examine patient logging system data from a 3-month evaluation of the I-Neb AAD system, Respir Drug Del, 3, 735
- Prince, 2006, I-Neb Insight: a new tool for monitoring inhaled medication use, Eur Respir J, 28, 261s
Cited by
Items 101–200 of 210
Medication Non-adherence in Older Adults: Underlying Factors, Potential Interventions and Outcomes
Raj, E. A., Vilakkathala, R., & George, J. (2025) · Drugs & Aging · doi:10.1007/s40266-025-01249-7 · Cited by 20
Grafton, K., Wheldon, C., Stiger, R. J., Robbins, N., Baker, C., & Jones, U. (2022) · Journal of the Association of Chartered Physiotherapists in Respiratory Care · doi:10.56792/lmmq6301 · Cited by 13
Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis
Smith, S. J., Calthorpe, R. J., Herbert, S., & Smyth, A. R. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013733.pub2 · Cited by 14
Staehelin, D., Dolata, M., Stöckli, L., & Schwabe, G. (2024) · JMIR Medical Informatics · doi:10.2196/57406 · Cited by 17
Akkerman‐Nijland, A. M., Grasmeijer, F., Kerstjens, H. A. M., Frijlink, H. W., van der Vaart, H., Vonk, J. M., Hagedoorn, P., Rottier, B. L., Koppelman, G. H., & Akkerman, O. W. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239658 · Cited by 13
Blardone, C., Gambazza, S., Mariani, A., Galgani, R., Brivio, A., Nobili, R., Rizza, C., Tutino, A. L., Gramegna, A., Daccò, V., et al. (2024) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666241235054 · Cited by 14
Gardner, A. J., Gray, A., Self, S. T., & Wagener, J. S. (2017) · Patient Preference and Adherence · doi:10.2147/ppa.s130439 · Cited by 12
“Monitoring adherence is challenging, as patient/caregiver self-reports and care team subjective assessments are often inaccurate, and other means of monitoring, including daily diaries or electronic monitors, add to the treatment burden and are not practical.(5,9) However, because suboptimal adherence is associated wi…”
BackgroundAbabneh, A., Finlayson, K. J., Edwards, H. E., Armstrong, D. G., Najafi, B., van Netten, J. J., & Lazzarini, P. A. (2023) · Sensors · doi:10.3390/s23094423 · Cited by 15
Hoo, Z. H., Jones, S., Babiker, N. T., Gardner, E., Royle, J., Curley, R., & Wildman, M. J. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s82896 · Cited by 13
“This categorization of adherence levels takes into account the median adherence with nebulized treatment of 36%.(5) Recruitment continued until data saturation occurred (ie, no new major themes emerged from additional participants).”
Osteoporosis Is Associated with Deteriorating Clinical Status in Adults with Cystic Fibrosis
Mathiesen, I. H. M., Pressler, T., Oturai, P., Katzenstein, T. L., Skov, M., Frikke‐Schmidt, R., & Hitz, M. F. (2018) · International Journal of Endocrinology · doi:10.1155/2018/4803974 · Cited by 12
“is as low as 50% of prescribed medications [27, 28]; this may further obscure a relationship between prescribed vitamin D doses and blood levels measured.”
BackgroundAdherence and barriers to general and respiratory exercises in cystic fibrosis
Santuzzi, C. H., Liberato, F. M. G., Morau, S. A. C., Ferreira, N. D. O., & Nascimento, L. R. (2020) · Pediatric Pulmonology · doi:10.1002/ppul.24912 · Cited by 14
“For instance, participants could have overestimated their adherence to the prescribed exercises.(40) Telemonitoring strategies could have been used to objectively estimate exercise initiation and exercise duration.”
BackgroundWildman, M. J., O’Cathain, A., Hind, D., Maguire, C., Arden, M. A., Hutchings, M., Bradley, J. M., Walters, S. J., Whelan, P., Ainsworth, J. D., et al. (2021) · Programme Grants for Applied Research · doi:10.3310/pgfar09110 · Cited by 14
Assessment of Inhaler Satisfaction and Determinants of High Satisfaction Among Korean COPD Patients
Jang, J. G., Lee, K. H., Chung, J. H., Shin, K. C., Choi, E. Y., Jin, H. J., & Ahn, J. H. (2022) · Journal of Korean Medical Science · doi:10.3346/jkms.2022.37.e327 · Cited by 11
An empirical method to cluster objective nebulizer adherence data among adults with cystic fibrosis
Hoo, Z. H., Campbell, M. J., Curley, R., & Wildman, M. J. (2017) · Patient Preference and Adherence · doi:10.2147/ppa.s131497 · Cited by 12
“The advantages of using objective adherence data for clustering include better accuracy and the ability to study adherence variability in detail.(8,26) There is uncertainty regarding some of the parameters chosen for this proposed method of clustering, but these parameters can be fine-tuned using a well-defined adhere…”
BackgroundGengiah, T. N., Upfold, M., Naidoo, A., Mansoor, L. E., Feldblum, P. J., Karim, Q. A., & Karim, S. S. A. (2014) · AIDS and Behavior · doi:10.1007/s10461-014-0750-y · Cited by 10
Pharmacists’ perspectives on monitoring adherence to treatment in Cystic Fibrosis
Mooney, K. M., Ryan, C. A., & Downey, D. G. (2015) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-015-0239-4 · Cited by 10
Use of inhaled antibiotics among Danish patients with cystic fibrosis
Møller, R., Nielsen, B. U., Faurholt‐Jepsen, D., Katzenstein, T. L., Skov, M., Philipsen, L. K. D., Pressler, T., Johansen, H. K., & Qvist, T. (2022) · Pediatric Pulmonology · doi:10.1002/ppul.25942 · Cited by 9
Prospects and Challenges: Inhalation Delivery Systems
Niven, R. W. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.18 · Cited by 10
Aspirin non-response in pregnant women at increased risk of pre-eclampsia
Vinogradov, R., Boag, C., Murphy, P., McGeeney, D., Kunadian, V., & Robson, S. C. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.09.036 · Cited by 12
Pulmonary exacerbation inflammatory phenotypes in adults with cystic fibrosis
Dong, K., Huh, S. M., Lam, G. Y., Jang, J., Franciosi, A. N., Wilcox, P., & Quon, B. S. (2022) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2022.12.013 · Cited by 9
Opportunities in Respiratory Drug Delivery
Pritchard, J. N., & Giles, R. D. (2014) · Therapeutic Delivery · doi:10.4155/tde.14.78 · Cited by 9
Hoo, Z. H., Wildman, M. J., Curley, R., Walters, S. J., & Campbell, M. J. (2017) · Respirology · doi:10.1111/resp.13174 · Cited by 10
Telemedicine and remote monitoring in cystic fibrosis
Edmondson, C. L., & Lechtzin, N. (2023) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000968 · Cited by 8
“Eighty-one adults with CF self-reported 3-month adherence to nebulizers as 80%, whereas median adherence downloaded from the nebulizers was only 36% [54].”
BackgroundIslam, M. R., Liu, C., Cai, C., Shah, J. K., & Feng, Y. (2024) · Physics of Fluids · doi:10.1063/5.0186786 · Cited by 8
“28 Therefore, inadequate inhalation practice and low adherence to the prescribed personalized treatment are two major factors in respiratory disease control failure among patients.”
BackgroundSpoletini, G., Pollard, K., Watson, R., Darby, M. J., Johnstone, A., Etherington, C., Whitaker, P., Clifton, I., & Peckham, D. G. (2020) · Respiratory Care · doi:10.4187/respcare.07862 · Cited by 9
“Adherence to treatment is of the utmost importance in CF, and, due to the significant burden of treatment, poor adherence remains a significant problem, being as low as 40–50%.(31,32) This results in negative health outcomes, including progression of lung disease and rate of pulmonary exacerbations.”
Self-citationBevan, A., Hoo, Z. H., Totton, N., Girling, C., Davids, I. R., Whelan, P., Antrobus, S., Ainsworth, J. D., Buchan, I. E., Anderson, A. J. B., et al. (2021) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2021.09.007 · Cited by 9
Self-citationSawicki, G. S., Goodman, A. S., Bacon, C., Collins, L., Greenberg, J., Duncan, C. L., Frederick, C., Luebbert, S., Mazuera, S., Polineni, D., et al. (2023) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2023.04.015 · Cited by 9
Dixon, E., Puckey, M., Collins, N., Marsh, G. S., & Pabary, R. (2019) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2019.04.002 · Cited by 9
Clinical Microsystems and Team Coaching
Harrison, S., Finn, R., & Godfrey, M. M. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009326360 · Cited by 8
Lumley, E., Drabble, S. J., Scott, A., Wildman, M. J., & O’Cathain, A. (2022) · Patient Preference and Adherence · doi:10.2147/ppa.s353434 · Cited by 9
“Traditionally, measurement of adherence has relied on subjective methods of assessment such as patient self-report, or clinician’s subjective assessment, both of which have been found to be inaccurate.(6,18) Nebulisers that electronically record nebulisation activity provide objective adherence data for nebuliser trea…”
MethodCurrent Practices in Airway Stent Management: A National Survey of US Practitioners
Wayne, M. T., Ali, M. S., Wakeam, E., Maldonado, F., Yarmus, L. B., Prescott, H. C., & Cardenas, J. D. (2023) · Respiration · doi:10.1159/000531500 · Cited by 7
Kelechi, T. J., Madisetti, M., Mueller, M., Dooley, M. J., & Prentice, M. A. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s91992 · Cited by 8
“Many studies have examined the accuracy of self-monitoring and self-reporting using paper diaries or study logs when compared with electronic monitoring devices with mixed results.(5) It is estimated that upon average, 20%–40% of self-reports are inaccurate due to a combination of missing data, patient errors in recor…”
BackgroundClinical outcomes of digital health in adults with cystic fibrosis
Carnovale, V., Iacotucci, P., Qiao, D., Ferrillo, L., Somma, J., Buonaurio, S., D’Ippolito, M., Celardo, A., & Savi, D. (2022) · Respiratory Medicine · doi:10.1016/j.rmed.2022.106970 · Cited by 5
Thornton, C. S., Somayaji, R., & Lim, R. K. (2022) · ERJ Open Research · doi:10.1183/23120541.00340-2022 · Cited by 6
Ridelman, D., Heisler, S., & Groves, A. (2024) · Journal of the American College of Emergency Physicians Open · doi:10.1002/emp2.13137 · Cited by 6
Randomised controlled trial of nebulised gentamicin in children with bronchiectasis
Twiss, J., Stewart, A. W., Gilchrist, C. A., Keelan, J. A., Metcalfe, R., & Byrnes, C. A. (2022) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.15899 · Cited by 8
Nevrekar, N., Butler, K., Shapiro, D. E., Atuhaire, P., Taha, T. E., Makanani, B., Chinula, L., Owor, M., Moodley, D., Chipato, T., et al. (2022) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003102 · Cited by 6
Exploration of the impact of ‘mild phenotypes’ ON median age at death IN the UK CF registry
Hoo, Z. H., Wildman, M. J., & Teare, M. D. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.02.012 · Cited by 6
A weekend/weekday comparison of adherence to daily treatment regimens in adults with cystic fibrosis
Keyte, R., Egan, H. H., Jackson, C. A., Nash, E. F., Regan, A., & Mantzios, M. (2017) · Health Psychology Report · doi:10.5114/hpr.2018.72331 · Cited by 5
Sandler, R. D., & Wildman, M. J. (2022) · Healthcare · doi:10.3390/healthcare11010020 · Cited by 10
“In CF, self-report and medicines:possession ratio overestimate adherence, compared to electronic data capture [27,31].”
BackgroundFénélon-Dimanche, R., Guénette, L., Trudel-Bourgault, F., Yousif, A., Lalonde, G., Beauchesne, M.-F., Collin, J., & Blais, L. (2020) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.04.022 · Cited by 8
Robinson, L., Maguire, C., Hoo, Z. H., & Wildman, M. J. (2020) · F1000Research · doi:10.12688/f1000research.21033.2 · Cited by 6
Hutchings, M., Kirkpatrick, S., Arden, M. A., Drabble, S. J., Maguire, C., Cantrill, H., Whelan, P., Hoo, Z. H., & Wildman, M. J. (2022) · Cureus · doi:10.7759/cureus.26511 · Cited by 6
“However, medication adherence is low in the range of 35-50% among adults with CF [1,2].”
BackgroundKnoch, M. (2024) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2024.29116.mk · Cited by 9
Riekert, K. A., Ford, C., Goodman, A. S., Eckmann, T., Green, A., & Quittner, A. L. (2024) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2024.10.011 · Cited by 6
Complex breathlessness: assessment of treatment adherence and treatable traits
McLoughlin, R. F., & McDonald, V. M. (2022) · European Respiratory Society eBooks · doi:10.1183/2312508x.10013721 · Cited by 5
The Effects of Cranberries on Preventing Urinary Tract Infections
Shin, C.-N. (2013) · Clinical Nursing Research · doi:10.1177/1054773813475448 · Cited by 5
“…method might be inaccurate due to over- or underreport of actual compliance because participants do not want to displease the researcher or health care provider, or because they are unaware of their actual compliance (Garfield, Clifford, Eliasson, Barber, & Willson, 2011; Daniels et al., 2011).”
MethodGirling, C., Packham, A., Robinson, L., Arden, M. A., Hind, D., & Wildman, M. J. (2022) · Implementation Science Communications · doi:10.1186/s43058-022-00263-9 · Cited by 6
“Subjective self-report measurements—the norm in routine practice—substantially overestimate adherence rates [16].”
BackgroundDawson, S., Rodham, K., Taylor, J. H., Dewar, J. C., & Wildman, M. J. (2023) · Psychology and Health · doi:10.1080/08870446.2023.2254318 · Cited by 7
“It is well known that patient self-report is unreliable (e.g. Daniels et al., 2011; Modi et al., 2006) and is subject to social desirability and recall bias (osterberg & Blaschke, 2005).”
InfluentialImplications of Disagreement Between Self-Reporting and Objective Measures: A Scoping Review
Shamsi, H. A., Almutairi, A. G., & Mashrafi, S. S. A. (2018) · Global Journal of Health Science · doi:10.5539/gjhs.v10n6p199 · Cited by 4
“(Daniels et al., 2011) Assessment of Adherence The median adherence level was at 80% (interquartile range, 57.”
BackgroundInfluentialMartin, R., Arden, M. A., Porritt, J. M., Wildman, M. J., & Naughton, F. (2020) · Healthcare · doi:10.3390/healthcare8010022 · Cited by 5
“[13] found that adults self‐reported 80% adherence levels, which corresponded with an adherence rate of only 36% for this group when using objective nebuliser reports taken from the I‐neb adaptive aerosol delivery (AAD) nebuliser system (Philips Respironics; Chichester, England).”
MethodTotton, N., Bradburn, M. J., Hoo, Z. H., Lewis, J., Hind, D., Girling, C., Shepherd, E., Nightingale, J. A., Daniels, T. W. V., Dewar, J. C., et al. (2021) · Health Science Reports · doi:10.1002/hsr2.381 · Cited by 3
Self-citationAdherence to inhaled therapies over 4 years in people with cystic fibrosis
Manika, Κ., Hatziagorou, E., Kotoulas, S., Kyrvasili, S., Sourla, E., Kouroukli, E., Sionidou, M., Papadaki, E., & Tsanakas, J. N. (2022) · Pediatric Pulmonology · doi:10.1002/ppul.25834 · Cited by 4
“It is known that the rate of adherence depends on the type of measurement and that pharmacy refill records provide an indirect estimation of adherence and often overestimate adherence compared to electronic monitors.(5,13) However, this is true for patients with either stable or variable adherence.”
BackgroundAdherence to Analgesics Among Outpatients Seriously Ill With Cancer
Stapleton, S. J., Dyal, B. W., Boyd, A. D., Suarez, M. L., Ezenwa, M. O., Yao, Y., & Wilkie, D. J. (2022) · Cancer Nursing · doi:10.1097/ncc.0000000000001064 · Cited by 4
Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis
Smith, S. J., Calthorpe, R. J., Herbert, S., & Smyth, A. R. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013733 · Cited by 4
Burke, L. E., Zheng, Y., & Wang, J. (2018) · Springer eBooks · doi:10.1007/978-0-387-93826-4_19 · Cited by 6
Richards, B., Osborne, S. R., & Simons, M. (2022) · BMC Health Services Research · doi:10.1186/s12913-021-07373-5 · Cited by 3
McCallion, P., Butler, J. A., Moloney, S., Bradley, J. M., & Soyza, A. D. (2022) · Journal of the Association of Chartered Physiotherapists in Respiratory Care · doi:10.56792/khov9356 · Cited by 4
Impact of Digital Technologies on Clinical Care for Adults with Cystic Fibrosis
Peckham, D. G., & Spoletini, G. (2022) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0042-1758730 · Cited by 3
“13,14 In a small study using data-logging of the I-neb device, overall adherencetoinhaled therapies wasfound to be reasonable.”
BackgroundSelf-citationAdherence in Young People Living With Juvenile Arthritis: A Systematic Review
Nelson, C. I., Noel, D., Caes, L., McCabe, K. M., & Duncan, C. L. (2023) · Clinical Practice in Pediatric Psychology · doi:10.1037/cpp0000483 · Cited by 4
“It is important to acknowledge that almost all the studies included in the current systematic review relied on self-report measures to examine adherence, which typically are highly subjective to bias (Daniels et al., 2011; Rand, 2000).”
Mattison, G., Canfell, O. J., Smith, D. B., Forrester, D. L., Reid, D. W., Töyräs, J., & Dobbins, C. (2024) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2024.105532 · Cited by 4
Corten, L., & Morrow, B. M. (2019) · Physiotherapy Practice and Research · doi:10.3233/ppr-190148 · Cited by 5
Interventions for improving adherence to treatment in cystic fibrosis
Jones, S., Curley, R., Wildman, M. J., Morton, R., & Elphick, H. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011665 · Cited by 3
RetractedPart I: Understanding the variation in adherence with nebulised treatment in Cystic Fibrosis
Hoo, Z. H., Gardner, B., Curley, R., Wildman, M. J., & Dodds, S. (2013) · Cited by 3
Factors Influencing Adherence to Treatment for Head and Neck Cancer
Starmer, H. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-04702-3_24 · Cited by 3
Sandler, R. D., Anderson, A. J. B., Barnett, T., Bourke, S., Cameron, S., Chapman, S. J., Choyce, J., Daniels, T. W. V., Daniels, T. E., Dawson, S., et al. (2025) · Respiratory Medicine · doi:10.1016/j.rmed.2025.107995 · Cited by 2
Self-citationLe, T. S., Paterson, D. I., Davies, N. M., & Mackey, J. R. (2020) · CMAJ Open · doi:10.9778/cmajo.20190147 · Cited by 2
A Patient with Asthma Seeks Medical Advice
O’Sullivan, B., Zwerdling, R. G., & Kremer, T. (2012) · New England Journal of Medicine · doi:10.1056/nejmc1203718 · Cited by 2
Factors affecting the use of antioxidant supplements in patients with late AMD
Yu, A., Paul, T., Schaumberger, M. M., & Welge‐Lüßen, U. (2014) · Clinical ophthalmology · doi:10.2147/opth.s64048 · Cited by 3
“Patients are more likely to give socially acceptable answers in self-report questionnaires.(12) We tried to overcome this problem by asking the exact name and dosing regimen of the supplement the patients used.”
Progress Towards Next-Generation Therapeutics for Cystic Fibrosis
O′Neil, D. A., & Fraser-Pitt, D. J. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.67 · Cited by 2
Understanding Treatment Adherence in Cystic Fibrosis: Challenges and Opportunities
Muther, E., Butcher, J. L., & Riekert, K. A. (2020) · Respiratory medicine · doi:10.1007/978-3-030-42382-7_22 · Cited by 4
Hoo, Z. H., & Wildman, M. J. (2020) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.09.017 · Cited by 2
Sandler, R. D., Lai, L. Y. H., Dawson, S., Cameron, S., Lynam, A., Sperrin, M., Hoo, Z. H., & Wildman, M. J. (2024) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2024.2328085 · Cited by 1
Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis
Calthorpe, R. J., Smith, S. J., Jahnke, N., Smyth, A. R., & supported by the Cochrane Cystic Fibrosis Review Group (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013733.pub3 · Cited by 2
Sandler, R. D., Lai, L. Y. H., Cameron, S., Dawson, S., Daniels, T. E., Wildman, M. J., Sperrin, M., & Hoo, Z. H. (2026) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2026.05.012 · Cited by 1
Self-citationMann, N., Murray, S., Hoo, Z. H., Curley, R., & Wildman, M. J. (2017) · F1000Research · doi:10.12688/f1000research.13298.1 · Cited by 1
Tappenden, P., Biz, A. N., Alava, M. H., Sasso, A., Sutton, L., Ennis, K., Elliott, R. A., & Wildman, M. J. (2023) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462322003373 · Cited by 1
“UK data using chipped nebulizers brought to the clinic to be downloaded suggest a lowermedian adherence rate of 36 percent (7).”
Abel, D., Anderson, D., Kallan, M. J., Utidjian, L., Burnham, J. M., Chang, J. C. H., Kenyon, C. C., & Gmuca, S. (2024) · Arthritis Care & Research · doi:10.1002/acr.25441 · Cited by 1
Dawson, S., Cowap, L., Clark-Carter, D. D., & Girling, C. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013766 · Cited by 1
Robinson, L., Maguire, C., Hoo, Z. H., & Wildman, M. J. (2019) · F1000Research · doi:10.12688/f1000research.21033.1 · Cited by 1
Driver, K., Major Trauma & Orthoplastics, M. R. I., Shaw-Núñez, E., & Shaffi, D. (2022) · Journal of the Association of Chartered Physiotherapists in Respiratory Care · doi:10.56792/yzdm2743 · Cited by 1
After a long wait, two arrive, one after the other!
Southern, K. W., McCormack, P., & McNamara, P. S. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202891 · Cited by 1
(2011) · Pediatric Pulmonology · doi:10.1002/ppul.21582 · Cited by 1
Intérêt des thérapeutiques inhalées dans la prise en charge des dilatations des bronches
Dury, S. (2013) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(13)70469-5
Nasr, S. Z., Chou, W., Villa, K. F., Chang, E. Y., & Broder, M. S. (2013)
Lifestyle treatments in cystic fibrosis: The NHS should not pay
Hull, J. (2016) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2016.06.007
Lifestyle treatments in cystic fibrosis: The NHS should pay
Ketchell, R. I. (2016) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2016.06.006
Mann, N., Murray, S., Hoo, Z. H., Curley, R., & Wildman, M. J. (2018) · F1000Research · doi:10.12688/f1000research.13298.2
Pharmacists as the delivery channel for adherence support in asthma
Mes, M. A. (2019) · UCL Discovery (University College London) · Cited by 1
Banks, J. T., Rosenfeld, M., Mancl, L., & Donald, L. (2020) · International Journal of Paediatric Dentistry · doi:10.1111/ipd.12724
The role of beliefs in predicting adherence to nebulised therapy in adolescents with cystic fibrosis
Stirzaker, B. M. (2020) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Arden, M. A., Hutchings, M., Whelan, P., Drabble, S. J., Beever, D., Bradley, J. M., Hind, D., Ainsworth, J. D., Maguire, C., Cantrill, H., et al. (2020) · doi:10.31234/osf.io/gbcpk
Review of the British Thoracic Society Winter Meeting 2021, 24–26 November 2021
Jha, A., Ward, T., Walker, S. P., Goodwin, A. T., & Chalmers, J. D. (2022) · Thorax · doi:10.1136/thorax-2022-219150
Sayer, K., Church, D., Grady, A., & Thomas, A. (2022) · Journal of the Association of Chartered Physiotherapists in Respiratory Care · doi:10.56792/qopl9891
Lewis, M. A., & Twose, P. (2022) · Journal of the Association of Chartered Physiotherapists in Respiratory Care · doi:10.56792/blrh7152
Shepherd, E., Douglas, H., & Osman, L. (2022) · Journal of the Association of Chartered Physiotherapists in Respiratory Care · doi:10.56792/vwji7953
Girling, C., Davids, I. R., Totton, N., Arden, M. A., Hind, D., & Wildman, M. J. (2024) · Learning Health Systems · doi:10.1002/lrh2.10453 · Cited by 14
“4 However, real-world adherence is between 30% and 50%, 5,6 meaning that PwCF are unlikely to be obtaining the optimal benefits.”
Sahota, N., Aziza, R., Komarzynski, S., Dixon, L., Dexter, K., Schofield, L., Peake, S., Davies, E. H., & Ferrer-Mallol, E. (2024) · Research Square · doi:10.21203/rs.3.rs-5159368/v1
Leysen, M., Nijs, J., van Wilgen, P., Demoulin, C., Pitance, L., Kuppens, K., Munneke, W., & Roussel, N. A. (2025) · Journal of Bodywork and Movement Therapies · doi:10.1016/j.jbmt.2025.06.010 · Cited by 1
Adherence to treatment in bronchiectasis: A challenge that physiotherapists can’t ignore
McCullough, A. R., & Bradley, J. M. (2014) · Bond University Research Portal (Bond University)
Metadata
- Authors
- Daniels, T., Goodacre, L., Sutton, C., Pollard, K., Conway, S., & Peckham, D.
- Affiliations
- York Hospital (GB)
- University of Lancashire (GB)
- Leeds Teaching Hospitals NHS Trust (GB)
- Corresponding author
- Daniels, Tracey
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2011-08
- Volume
- 140
- Issue
- 2
- Pages
- 425-432
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2086921502
- Cited by
- 210
- References
- 27
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 11 · 2023: 12 · 2022: 32 · 2021: 13 · 2020: 18 · 2019: 15 · 2018: 11 · 2017: 16 · 2016: 14 · 2015: 15 · 2014: 17 · 2013: 14 · 2012: 7
- FWCI
- 12.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- CHEST Journal (publishedVersion)
- PubMed (publishedVersion)
- CLOK (University of Central Lancashire) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Keywords
- cystic fibrosis, medication adherence, electronic monitoring, self-report, treatment burden
- MeSH terms
- Adult, Cystic Fibrosis, Electronics, Female, Humans, Male, Nebulizers and Vaporizers, Medication Adherence, Young Adult, Self Report
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.